Table 3.
Comparison of demographics, clinical characteristics, laboratory data, and inflammatory cytokines between the N and L groups in elderly participants.
| Elderly | N (n = 130) | L (n = 24) | p |
|---|---|---|---|
| Male/female | 67/63 | 11/13 | 0.385 |
| Age (yrs) | 70.0 ± 4.7 | 74.2 ± 6.7 | 0.002 |
| BMI (kg/m2) | 24.1 ± 3.1 | 20.9 ± 2.5 | <0.001 |
| BFP (%) | 27.7 ± 6.6 | 25.5 ± 6.2 | 0.082 |
| Gait speed (m/s) | 2.63 ± 0.46 | 2.75 ± 0.46 | 0.257 |
| Smoking history (y/n) | 13/117 | 4/20 | 0.307 |
| Hypertension (y/n) | 57/73 | 9/15 | 0.365 |
| Diabetes (y/n) | 9/121 | 4/20 | 0.122 |
| Hyperlipidemia (y/n) | 50/80 | 9/15 | 0.560 |
| HbA1c (%) | 5.8 ± 0.5 | 5.8 ± 0.5 | 0.889 |
| Alb (g/dl) | 4.26 ± 0.27 | 4.22 ± 0.16 | 0.323 |
| AST (U/I) | 24.4 ± 8.0 | 27.0 ± 11.0 | 0.356 |
| ALT (U/I) | 23.9 ± 13.0 | 19.8 ± 8.0 | 0.185 |
| T-cho (mg/dl) | 207.2 ± 34.8 | 204.9 ± 41.9 | 0.464 |
| BUN (mg/dl) | 16.4 ± 4.3 | 16.2 ± 4.2 | 0.936 |
| Cre (mg/dl) | 0.83 ± 0.37 | 0.78 ± 0.10 | 0.974 |
| CRP (mg/dl) | 0.12 ± 0.36 | 0.15 ± 0.34 | 0.707 |
| TNF-alpha (pg/ml) | 11.8 ± 11.6 | 7.0 ± 8.0 | 0.041 |
| IL-6 (pg/ml) | 6.4 ± 9.5 | 5.0 ± 4.5 | 0.442 |
| MCP-1 (pg/ml) | 60.5 ± 66.3 | 56.7 ± 51.5 | 0.864 |
BMI: body mass index. BFP: body fat percentage; N: N group (ASMI ≥ 7.0 kg/m2 and 5.7 kg/m2 in men and women, respectively); L: L group (ASMI < 7.0 kg/m2 and 5.7 kg/m2 in men and women, respectively); ASMI: appendicular skeletal muscle mass; appendicular soft lean mass/(height)2.